Photo by nci from unsplash
9100Background: Tyrosine Kinase inhibitors (TKI) have changed the treatment paradigm in patients with stage IV adenocarcinoma of the lung (AdenoCa) harboring epidermal growth factor receptor (EGFR)... Click to show full abstract
9100Background: Tyrosine Kinase inhibitors (TKI) have changed the treatment paradigm in patients with stage IV adenocarcinoma of the lung (AdenoCa) harboring epidermal growth factor receptor (EGFR)...
Keywords:
adenocarcinoma lung;
reporting stage;
stage adenocarcinoma;
egfr reporting
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!